Global Oral Antiviral Medications for COVID-19 Market Growth 2023-2029

Global Oral Antiviral Medications for COVID-19 Market Growth 2023-2029

Lagevrio and Paxlovid have both been found to be effective in treating mild to moderate COVID-19 in adults aged 18 years of age and older, who do not require supplemental oxygen, and who are at increased risk of progression to hospitalisation. The advantage of these oral medications is that many people will be able to receive treatment for COVID-19 in their own homes without the need to travel to hospital for treatment as an inpatient.

LPI (LP Information)' newest research report, the “Oral Antiviral Medications for COVID-19 Industry Forecast” looks at past sales and reviews total world Oral Antiviral Medications for COVID-19 sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Antiviral Medications for COVID-19 sales for 2023 through 2029. With Oral Antiviral Medications for COVID-19 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Antiviral Medications for COVID-19 industry.

This Insight Report provides a comprehensive analysis of the global Oral Antiviral Medications for COVID-19 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Antiviral Medications for COVID-19 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Antiviral Medications for COVID-19 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Antiviral Medications for COVID-19 and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Antiviral Medications for COVID-19.

The global Oral Antiviral Medications for COVID-19 market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Oral Antiviral Medications for COVID-19 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Oral Antiviral Medications for COVID-19 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Oral Antiviral Medications for COVID-19 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Oral Antiviral Medications for COVID-19 players cover Pfizer, Merck, Shionogi, Frontier Biotechnologies, Simcere Pharmaceutical and Guangdong Zhongsheng, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antiviral Medications for COVID-19 market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Tablet
Capsule

Segmentation by application
Hospital
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Merck
Shionogi
Frontier Biotechnologies
Simcere Pharmaceutical
Guangdong Zhongsheng

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Antiviral Medications for COVID-19 market?

What factors are driving Oral Antiviral Medications for COVID-19 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Antiviral Medications for COVID-19 market opportunities vary by end market size?

How does Oral Antiviral Medications for COVID-19 break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.